These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19118594)

  • 1. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.
    Rots NY; Wijmenga-Monsuur AJ; Luytjes W; Kaaijk P; de Graaf TW; van der Zeijst BA; Boog CJ
    Vaccine; 2010 Jan; 28(4):893-900. PubMed ID: 19932217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [National hepatitis B vaccination closer to implementation, but not soon enough; recommendations from the Dutch Health Council].
    Galama JM
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1339-42. PubMed ID: 11484429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hepatitis B for travelers: is vaccination for all travelers really necessary?
    Sonder GJ; van Rijckevorsel GG; van den Hoek A
    J Travel Med; 2009; 16(1):18-22. PubMed ID: 19192123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and prevention of hepatitis B.
    Alter MJ
    Semin Liver Dis; 2003 Feb; 23(1):39-46. PubMed ID: 12616449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination and changes in sexual risk behaviour among men who have sex with men in Amsterdam.
    Xiridou M; Wallinga J; Dukers-Muijers N; Coutinho R
    Epidemiol Infect; 2009 Apr; 137(4):504-12. PubMed ID: 18631424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
    Thornley S; Bullen C; Roberts M
    J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions].
    Koedijk FD; op de Coul EL; Boot HJ; van de Laar MJ
    Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2389-94. PubMed ID: 18019217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina.
    Salkic NN; Zildzic M; Muminhodzic K; Pavlovic-Calic N; Zerem E; Ahmetagic S; Mott-Divkovic S; Alibegovic E
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):113-8. PubMed ID: 17272995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk].
    de Man RA
    Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2365-6. PubMed ID: 18019211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Gidding HF; Warlow M; MacIntyre CR; Backhouse J; Gilbert GL; Quinn HE; McIntyre PB
    Vaccine; 2007 Dec; 25(51):8637-41. PubMed ID: 18054127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.